Home › Funds › Nextech Invest Ltd. › CNTX
Nextech Invest Ltd. position in CNTX
CONTEXT THERAPEUTICS INC · Health Care
Nextech Invest Ltd. reported holding 7,419,355 shares of CNTX (CONTEXT THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$4.1M, representing 0.20% of its reported portfolio and ranking #14 among its reported holdings. Nextech Invest Ltd. has disclosed CNTX holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Nextech Invest Ltd.'s CNTX position evolved
Nextech Invest Ltd. first disclosed a stake in CNTX in Q1 2025 at 7,419,355 shares (US$4.5M). The position peaked in Q1 2026 at 7,419,355 shares, worth US$19.4M. Across 6 filings, Nextech Invest Ltd. held the position steady without any share-count change. The most recent filing (Q2 2026) shows 7,419,355 shares valued at US$4.1M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 7.42M | $4.54M | New |
| Q2 2025 | 7.42M | $4.86M | Hold |
| Q3 2025 | 7.42M | $7.19M | Hold |
| Q4 2025 | 7.42M | $10.91M | Hold |
| Q1 2026 | 7.42M | $19.44M | Hold |
| Q2 2026 | 7.42M | $4.11M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CNTX and 13F data
CNTX (CONTEXT THERAPEUTICS INC) is a Health Care company. 36 other funds we track also report a position in CNTX — the largest reported positions include Avidity Partners Management LP (US$2.8M), Octagon Capital Advisors LP (US$1.7M), Blue Owl Capital Holdings LP (US$1.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CNTX
- Avidity Partners Management LP 5.00M sh · $2.77M · Q2 2026
- Octagon Capital Advisors LP 3.05M sh · $1.69M · Q2 2026
- Blue Owl Capital Holdings LP 2.93M sh · $1.63M · Q2 2026
- MPM BioImpact LLC 1.30M sh · $719.54K · Q2 2026
More on Nextech Invest Ltd.
FAQ
How long has Nextech Invest Ltd. held CNTX?
Nextech Invest Ltd. has disclosed CNTX holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
What is Nextech Invest Ltd.'s current position in CNTX?
As of Q2 2026, Nextech Invest Ltd. holds 7.42M shares of CNTX (CONTEXT THERAPEUTICS INC), valued at $4.11M, representing 0.20% of its reported portfolio and ranking #14.
Has Nextech Invest Ltd. been buying or selling CNTX?
In the latest 13F filing (Q2 2026), Nextech Invest Ltd. held unchanged its position in CNTX. The position peaked in Q1 2026 at 7.42M shares.
Which other funds hold CNTX?
Other major institutional holders of CNTX include Avidity Partners Management LP, Octagon Capital Advisors LP, Blue Owl Capital Holdings LP, among 36 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.